Evidence map›Paper›PMID 25077544›Full record

ArticleCell death & disease2014

JNK1/2 regulate Bid by direct phosphorylation at Thr59 in response to ALDH1L1.

A Prakasam, S Ghose, N V Oleinik, J R Bethard, Y K Peterson, N I Krupenko, S A Krupenko

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Understanding MAPK Signaling Pathways in Apoptosis.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

A PrakasamDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
S GhoseDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
N V OleinikDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
J R BethardCell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
Y K PetersonDrug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, SC, USA.
N I Krupenko1] Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA [2] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
S A Krupenko1] Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA [2] Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
MECHANISM OF ACTIONS OF A MAJOR FOLATE ENZYMER01DK054388 · NIDDK · VANDERBILT UNIVERSITY · PI KRUPENKO, SERGEY A · 1998 to 2015
$4.7M
FDH: A Novel Determinant of Tumor SuppressionR01CA095030 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KRUPENKO, SERGEY A · 2005 to 2014
$2.5M
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
NCI NIH HHS CA095030NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA095030NIDDK NIH HHS DK054388NIDDK NIH HHS R01 DK054388NIH HHS S10 OD010731
6 · The paper itself

Abstract

BH3 interacting-domain death agonist (Bid) is a BH3-only pro-apoptotic member of the Bcl-2 family of proteins. Its function in apoptosis is associated with the proteolytic cleavage to the truncated form tBid, mainly by caspase-8. tBid translocates to mitochondria and assists Bax and Bak in induction of apoptosis. c-Jun N-terminal kinase (JNK)-dependent alternative processing of Bid to jBid was also reported. We have previously shown that the folate stress enzyme 10-formyltetrahydrofolate dehydrogenase (ALDH1L1) activates JNK1 and JNK2 in cancer cells as a pro-apoptotic response. Here we report that in PC-3 prostate cancer cells, JNK1/2 phosphorylate Bid at Thr59 within the caspase cleavage site in response to ALDH1L1. In vitro, all three JNK isoforms, JNK 1-3, phosphorylated Thr59 of Bid with JNK1 being the least active. Thr59 phosphorylation protected Bid from cleavage by caspase-8, resulting in strong accumulation of the full-length protein and its translocation to mitochondria. Interestingly, although we did not observe jBid in response to ALDH1L1 in PC-3 cells, transient expression of Bid mutants lacking the caspase-8 cleavage site resulted in strong accumulation of jBid. Of note, a T59D mutant mimicking constitutive phosphorylation revealed more profound cleavage of Bid to jBid. JNK-driven Bid accumulation had a pro-apoptotic effect in our study: small interfering RNA silencing of either JNK1/2 or Bid prevented Bid phosphorylation and accumulation, and rescued ALDH1L1-expressing cells. As full-length Bid is a weaker apoptogen than tBid, we propose that the phosphorylation of Bid by JNKs, followed by the accumulation of the full-length protein, delays attainment of apoptosis, and allows the cell to evaluate the stress and make a decision regarding the response strategy. This mechanism perhaps can be modified by the alternative cleavage of phospho-T59 Bid to jBid at some conditions.

Indexed as

Aldehyde DehydrogenaseAmino Acid MotifsBH3 Interacting Domain Death Agonist ProteinCaspase 8Cell Line, TumorFormyltetrahydrofolate DehydrogenaseHumansMaleMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9Oxidoreductases Acting on CH-NH Group DonorsPhosphorylationProstatic NeoplasmsThreonineAldehyde DehydrogenaseBH3 Interacting Domain Death Agonist ProteinCaspase 8Formyltetrahydrofolate DehydrogenaseMitogen-Activated Protein Kinase 8Mitogen-Activated Protein Kinase 9Oxidoreductases Acting on CH-NH Group DonorsThreonine

Identifiers

PMID25077544
PMCPMC4123105
OpenAlexW2058520242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.